Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
Ulta Beauty Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $23.3B | |
|---|---|---|
| Revenue (ttm) | 13B | |
| Net income (ttm) | 1.2B | |
| EPS (ttm) | $27.4 | |
| Shares out | 42.8M | |
| P/E (trailing) | 22.5x | |
| P/E (forward) | 19.6x | |
| Volume | 348,647 | |
| Beta | 0.84 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-29 | 2023-01-28 | 2024-02-03 | 2025-02-01 | 2026-01-31 | Trend |
| Revenue | $8.63B | $10.21B | $11.21B | $11.30B | $12.39B | +9.5% |
| Gross profit | $3.37B | $4.04B | $4.38B | $4.39B | $4.85B | +9.5% |
| Operating income | $1.30B | $1.64B | $1.68B | $1.56B | $1.53B | +4.3% |
| Net income | $985.8M | $1.24B | $1.29B | $1.20B | $1.15B | +4.0% |
| EPS (diluted) | $17.98 | $24.01 | $26.03 | $25.34 | $25.64 | +9.3% |
| EBITDA | $1.57B | $1.88B | $1.94B | $1.85B | $1.83B | +4.0% |
| R&D | $926.0K | $1.0M | $889.0K | $306.0K | — | -30.9% |
| SG&A | $2.06B | $2.40B | $2.69B | $2.81B | $3.30B | +12.5% |
Recent company headlines from major financial publishers.
Net sales compound moderately and operating margins remain stable. Store-fulfilled digital orders leverage retail fixed overhead, counterbalanced by persistent promotional activity. Substantial free cash flow generation and disciplined share repurchases support steady per-share compounding through FY2028.
Prestige beauty product innovation, category expansion into wellness routines, and store-fulfilled digital efficiencies drive accelerating comparable store sales growth and operating margin expansion, supporting robust earnings compounding alongside authorized capital return programs.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.2% | $520 | $532 | $544 | $558 | $573 |
| 8.7% | $493 | $502 | $513 | $524 | $536 |
| 9.2% | $470 | $477 | $486 | $495 | $505 |
| 9.7% | $449 | $456 | $463 | $470 | $479 |
| 10.2% | $431 | $437 | $443 | $449 | $456 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |